Patient Reported Outcomes in patients received DVd for relapsed MM (ACTRN12618000659202)
PRO-DVd
This trial is No longer recruiting
Registration number ACTRN12618000659202
Program & service
This trial is being run with the Cancer service, and as part of the Haematology program.
Trial phase
Other
Trial participation type
This trial is for clinical research of something other than a drug or device.
Principal investigator
Professor Andrew Spencer
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR